Insider Buying: Johnson Matthey (LON:JMAT) Insider Buys £229.08 in Stock

Johnson Matthey PLC (LON:JMATGet Free Report) insider Alastair Judge acquired 12 shares of the business’s stock in a transaction that occurred on Friday, July 10th. The stock was acquired at an average cost of GBX 1,909 per share, with a total value of £229.08.

Alastair Judge also recently made the following trade(s):

  • On Wednesday, June 10th, Alastair Judge bought 14 shares of Johnson Matthey stock. The shares were acquired at an average cost of GBX 1,990 per share, for a total transaction of £278.60.
  • On Wednesday, May 13th, Alastair Judge bought 10 shares of Johnson Matthey stock. The shares were bought at an average price of GBX 2,158 per share, for a total transaction of £215.80.
  • On Wednesday, April 15th, Alastair Judge purchased 14 shares of Johnson Matthey stock. The stock was bought at an average cost of GBX 2,022 per share, with a total value of £283.08.

Johnson Matthey Stock Performance

Shares of LON JMAT traded up GBX 29.29 during mid-day trading on Monday, hitting GBX 1,924. The company had a trading volume of 362,535 shares, compared to its average volume of 2,669,878. The company has a current ratio of 1.56, a quick ratio of 0.76 and a debt-to-equity ratio of 69.69. Johnson Matthey PLC has a 1 year low of GBX 1,730.72 and a 1 year high of GBX 2,434. The company has a market capitalization of £3.23 billion, a price-to-earnings ratio of -33.64, a P/E/G ratio of 49,242.50 and a beta of 0.94. The stock’s 50-day moving average price is GBX 2,076.73 and its 200-day moving average price is GBX 2,105.16.

Johnson Matthey (LON:JMATGet Free Report) last posted its earnings results on Thursday, May 28th. The company reported GBX 128.50 earnings per share for the quarter. The business had revenue of GBX 1,257.30 billion during the quarter. Johnson Matthey had a negative return on equity of 4.66% and a negative net margin of 0.76%. On average, sell-side analysts forecast that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on JMAT shares. Jefferies Financial Group reiterated a “restricted” rating on shares of Johnson Matthey in a report on Friday, May 29th. Berenberg Bank upped their price objective on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research report on Monday, June 1st. UBS Group reissued a “neutral” rating and issued a GBX 2,200 target price on shares of Johnson Matthey in a report on Friday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 2,400 price target on shares of Johnson Matthey in a report on Monday, July 6th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of GBX 2,298.33.

View Our Latest Report on Johnson Matthey

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

Featured Articles

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.